Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
---|
09/04/2003 | US20030165896 Inhibitors of human plasmin derived from the kunitz domains |
09/04/2003 | US20030165891 Novel TWIK-6, TWIK-7, IC23927, TWIK-8, IC47611, IC47615, HNMDA-1, TWIK-9 alpha2delta-4, 54414, and 53763 molecules and uses therefor |
09/04/2003 | US20030165889 Identifying and detecting virulence determinant genes of Legionella pneumophila in cells; diagnosing infections |
09/04/2003 | US20030165887 Diagnosing tumors by monitor concentration and expression of tumor up regulated card containing antagonist of caspase nine (TUCAN) polypeptides; monitoring success of treatments with antitumor agents |
09/04/2003 | US20030165886 EGF motif protein, EGFL6 materials and methods |
09/04/2003 | US20030165881 Novel nucleic acids and polypeptides |
09/04/2003 | US20030165878 Novel compositions and methods in cancer associated with altered expression of MCM3AP |
09/04/2003 | US20030165875 Novel receptor TREM (triggering receptor expressed on myeloid cells) and uses thereof |
09/04/2003 | US20030165858 Novel GPCR-like proteins and nucleic acids encoding same |
09/04/2003 | US20030165851 Novel polypetides and nucleic acids encoding same |
09/04/2003 | US20030165834 Using colon cancer associated polypeptides (CCP) for diagnosing and detecting rectal tumors; immunoassays |
09/04/2003 | US20030165831 Comprise nucleotide sequences for diagnosing and treating gynecological tumors; antitumor/anticarcinogenic agents |
09/04/2003 | US20030165829 Novel proteins and nucleic acids encoding same |
09/04/2003 | US20030165820 Compositions and methods for the diagnosis and treatment of herpes simplex virus infection |
09/04/2003 | US20030165819 Compositions and methods for the diagnosis and treatment of herpes simplex virus infection |
09/04/2003 | US20030165818 Detecting modulators of serine protease/dipeptidyl peptidase activity for treating viral/muscular/bone/nervous system disorders |
09/04/2003 | US20030165807 Methods for identifying compounds for regulating muscle mass or function using corticotropin releasing factor receptors |
09/04/2003 | US20030165582 Plant extracts; aging resistance; skin disorders |
09/04/2003 | US20030165575 Methods and compositions for treatment and diagnosis of alzheimer disease and other disorders |
09/04/2003 | US20030165574 Compositions and methods for treatment of body weight conditions |
09/04/2003 | US20030165567 Administering polypeptide by injection; gene therapy |
09/04/2003 | US20030165555 Administering active polypeptide |
09/04/2003 | US20030165548 Process for producing functional silk fibroin and utilization of the same |
09/04/2003 | US20030165541 Using botulinum toxin |
09/04/2003 | US20030165539 Chimeric vaccine against tick-borne encephalitis virus |
09/04/2003 | US20030165531 Flt3-ligand as a vaccine adjuvant |
09/04/2003 | US20030165530 Adipocyte complement related protein homolog zacrp3 |
09/04/2003 | US20030165525 TB diagnostic based on antigens from M. tuberculosis |
09/04/2003 | US20030165519 Administering complex of protein taken from original tumor |
09/04/2003 | US20030165514 Modulate immunology response |
09/04/2003 | US20030165510 Antiinflammatory agents; anticancer agents; cholesterol binding protein |
09/04/2003 | US20030165509 Compositions and methods for homoconjugates of antibodies which induce growth arrest or apoptosis of tumor cells |
09/04/2003 | US20030165506 Novel alpha-catenin expressed in heart and testis |
09/04/2003 | US20030165504 Compositions and methods for the therapy and diagnosis of ovarian cancer |
09/04/2003 | US20030165499 Compositions and methods for treating psoriasis |
09/04/2003 | US20030165497 RRP sequences and knockout mice and uses thereof |
09/04/2003 | US20030165496 Alzheimer's disease |
09/04/2003 | US20030165493 Antithrombin protein and DNA sequences from black fly |
09/04/2003 | US20030165492 Administering Dna sequences; genetic engineering |
09/04/2003 | US20030165491 Anticancer agents; controlling cell differentiation; complexing; insertion plasmids; genetic engineering |
09/04/2003 | US20030165490 22196, a novel human aminopeptidase |
09/04/2003 | US20030165489 Method of treating rhinitis or sinusitis |
09/04/2003 | US20030165488 Polypeptides; culture product |
09/04/2003 | US20030165487 Amylase feed supplements for improved ruminant nutrition |
09/04/2003 | US20030165485 Functional role and potential therapeutic use of Reelin, Gas6 and Protein S in relation to adult neural stem or progenitor cells |
09/04/2003 | US20030165482 Skin disorders; wound healing agents; antiscarring agents |
09/04/2003 | US20030165481 Amyloid peptide inactivating enzyme to treat Alzheimer's disease |
09/04/2003 | US20030165473 Mixture of Dna, glycoprotein and collagen |
09/04/2003 | US20030165467 Angiogenic factor and use thereof in treating cardiovascular disease |
09/04/2003 | US20030165465 Treatment of neoplasms with viruses |
09/04/2003 | US20030165464 In vivo stimulation of angiogenic activity |
09/04/2003 | US20030165462 Deleted adenovirus vectors and methods of making and administering the same |
09/04/2003 | US20030165461 Colony stimulating factor culture product; human gene therapy |
09/04/2003 | US20030165460 Proteins which control cell differentiation; immunology response; antiinflammatory agents; wound healing agents |
09/04/2003 | US20030165459 Binding to tumor necrosis factor |
09/04/2003 | US20030165458 Anticholesterol agents; anticholesterol agents; immunology diseases; autoimmune diseases |
09/04/2003 | US20030165436 Formulations for use in inhaler devices |
09/04/2003 | US20030165432 Versatile hydrophilic dyes |
09/04/2003 | CA2483556A1 Hsp70-derived peptides an uses thereof in the diagnosis and treatment of autoimmune diseases |
09/04/2003 | CA2479812A1 Glutaminyl based dpiv inhibitors |
09/04/2003 | CA2477417A1 Methods and products based on oligomerization of stress proteins |
09/04/2003 | CA2477409A1 Process for the preparation of hypoallergenic major birch pollen allergen rbet v 1 |
09/04/2003 | CA2477408A1 An obligate domain-swapped dimer of cyanovirin with enhanced anti-viral activity |
09/04/2003 | CA2477309A1 Screening process |
09/04/2003 | CA2477249A1 Novel type-1 cytokine receptor glm-r |
09/04/2003 | CA2477231A1 Methods and compositions for treating gastrointestinal toxicity induced by cytoablative therapy |
09/04/2003 | CA2477225A1 Novel compositions and methods for cancer |
09/04/2003 | CA2477178A1 Administration of agents for the treatment of inflammation |
09/04/2003 | CA2477105A1 Ambroxol for the treatment of painful conditions in the mouth and pharyngeal cavity |
09/04/2003 | CA2477094A1 Ricin vaccine and methods of making and using thereof |
09/04/2003 | CA2477038A1 Use of peptide-drug conjugation to reduce inter-subject variability of drug serum levels |
09/04/2003 | CA2477037A1 Recombinant negative strand virus rna expression systems and vaccines |
09/04/2003 | CA2476994A1 Methods of extending corneal graft survival |
09/04/2003 | CA2476887A1 Gasp1:a follistatin domain containing protein |
09/04/2003 | CA2476846A1 Method for detection of leptin receptor ligands |
09/04/2003 | CA2476770A1 Human analogs of murine deubiquitinating protease genes |
09/04/2003 | CA2476765A1 Methods of preventing or treating brain ischemia or brain injury |
09/04/2003 | CA2476654A1 Follistatin domain containing proteins |
09/04/2003 | CA2476571A1 Method for isolating ligands |
09/04/2003 | CA2476518A1 Compositions and methods for the treatment of immune related diseases |
09/04/2003 | CA2475985A1 Method of stimulation of melanin production and induction of skin tanning |
09/04/2003 | CA2475953A1 Angiotensin-(1-7) and angiotensin-(1-7) agonists for inhibition of cancer cell growth |
09/04/2003 | CA2475653A1 (substituted)acyl dipeptidyl inhibitors of the ice/ced-3 family of cysteine proteases |
09/04/2003 | CA2475433A1 Trpm-2 antisense therapy using an oligonucleotide having 2'-o-(2-methoxyl)ethyl modifications |
09/04/2003 | CA2475039A1 Macromolecular conjugates and processes for preparing same |
09/04/2003 | CA2473340A1 Formulations comprising a glp-1 compound and a delivery agent, and uses thereof |
09/04/2003 | CA2467833A1 Pharmaceutical compositions in particulate form |
09/03/2003 | EP1340979A2 Neuropeptide receptor and uses thereof |
09/03/2003 | EP1340815A2 Determination of alpha-N-acetylgalactosaminidase activity |
09/03/2003 | EP1340811A2 Antibodies with specificity for multiple adhesion molecules |
09/03/2003 | EP1340769A1 CD4-gamma2 and CD4-IgG2 chimeras |
09/03/2003 | EP1340768A2 LHRH analogues for the treatment of osteoporosis |
09/03/2003 | EP1340765A2 Inverted chimeric and hybrid oligonucleotides |
09/03/2003 | EP1340507A1 Use of fibroblast growth factor-binding protein for the treatment and diagnosis of diabetic wound healing |
09/03/2003 | EP1340506A1 Compositions comprising pulmonary surfactants and a polymyxin having improved surface properties |
09/03/2003 | EP1340505A2 Therapeutic use of cis-element decoys in vivo |
09/03/2003 | EP1340084A2 Proteins, genes and their use for diagnosis and treatment of chronic asthma |
09/03/2003 | EP1340079A2 S. aureus protein staau-r2, gene encoding it and uses thereof |
09/03/2003 | EP1339871A1 Diagnosis and treatment of tumor-suppressor associated disorders |
09/03/2003 | EP1339862A1 Photochemical internalization for virus-mediated molecule delivery into the cyosol |